Prescription drug · ANDA
Aripiprazole NDC 50090-6403
Aripiprazole 20 mg/1 · Tablet · Oral · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-6403-0 | 50090640300 | 30 TABLET in 1 BOTTLE (50090-6403-0)Marketed from Mar 22, 2023 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Aripiprazole
- Generic name (nonproprietary)
- aripiprazole
- Active ingredients
- Aripiprazole — 20 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203908
- Marketing start
- Listing expires
- Identifiers
- Product ID 50090-6403_69b0cc5d-115d-42e1-a954-29001d35b693SPL ID 69b0cc5d-115d-42e1-a954-29001d35b693SPL set ID c8a94428-b6d2-428b-a3a5-7b983d572fabRxCUI 349553UNII 82VFR53I78
- Pharmacologic class
- Atypical Antipsychotic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450090640300followed by a unit qualifier and the quantityPackage 50090-6403-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Aripiprazole tablets are indicated for the treatment of: Schizophrenia Irritability Associated with Autistic Disorder Treatment of Tourette’s Disorder Aripiprazole is an atypical antipsychotic. The oral formulation is indicated for: Schizophrenia (14.1) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette’s disorder ( 14.5 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 203908
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Aripiprazole | Aripiprazole 5 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-662 |
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-661 |
| Aripiprazole | Aripiprazole 30 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-666 |
| Aripiprazole | Aripiprazole 10 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-663 |
| Aripiprazole | Aripiprazole 15 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-664 |
| Aripiprazole | Aripiprazole 20 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-665 |
| Aripiprazole | Aripiprazole 15 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4745 |
| Aripiprazole | Aripiprazole 5 mg/1 | TabletOral | Proficient Rx LP | 71205-392 |
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | Proficient Rx LP | 71205-480 |
| Aripiprazole | Aripiprazole 10 mg/1 | TabletOral | Proficient Rx LP | 82804-023 |
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | A-S Medication Solutions | 50090-7564 |
| Aripiprazole | Aripiprazole 20 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1364 |